Cedars-Sinai Diabetes and Obesity Research Institute, Los Angeles, CA.
Cedars-Sinai Diabetes and Obesity Research Institute, Los Angeles, CA
Diabetes. 2017 Jul;66(7):1742-1747. doi: 10.2337/db16-1320.
On the basis of studies that investigated the intraportal versus systemic insulin infusion and transendothelial transport of insulin, we proposed the "single gateway hypothesis," which supposes an indirect regulation of hepatic glucose production by insulin; the rate-limiting transport of insulin across the adipose tissue capillaries is responsible for the slow suppression of free fatty acids (FFAs), which in turn is responsible for delayed suppression of hepatic endogenous glucose production (EGP) during insulin infusion. Preventing the fall in plasma FFAs during insulin infusion either by administering intralipids or by inhibiting adipose tissue lipolysis led to failure in EGP suppression, thus supporting our hypothesis. More recently, mice lacking hepatic Foxo1 in addition to Akt1 and Akt2 (L-AktFoxo1TKO), all required for insulin signaling, surprisingly showed normal glycemia. Inhibiting the fall of plasma FFAs in these mice prevented the suppression of EGP during a clamp, reaffirming that the site of insulin action to control EGP is extrahepatic. Measuring whole-body turnover rates of glucose and FFAs in L-AktFoxo1TKO mice also confirmed that hepatic EGP was regulated by insulin-mediated control of FFAs. The knockout mouse model in combination with sophisticated molecular techniques confirmed our physiological findings and the single gateway hypothesis.
基于研究门静脉内与全身胰岛素输注和胰岛素跨内皮转运,我们提出了“单一门户假说”,该假说假设胰岛素对肝葡萄糖生成有间接调节作用;胰岛素穿过脂肪组织毛细血管的限速转运负责游离脂肪酸(FFAs)的缓慢抑制,而游离脂肪酸的缓慢抑制又负责胰岛素输注期间肝内源性葡萄糖生成(EGP)的延迟抑制。在胰岛素输注期间通过给予脂肪乳剂或抑制脂肪组织脂肪分解来防止血浆 FFAs 下降会导致 EGP 抑制失败,从而支持我们的假说。最近,除 Akt1 和 Akt2(L-AktFoxo1TKO)外,还缺乏肝 Foxo1 的小鼠(所有这些都是胰岛素信号所必需的),令人惊讶的是表现出正常的血糖水平。在这些小鼠中抑制血浆 FFAs 的下降可防止钳夹期间 EGP 的抑制,再次证实胰岛素作用以控制 EGP 的部位是肝外的。测量 L-AktFoxo1TKO 小鼠的全身葡萄糖和 FFAs 周转率也证实了肝 EGP 是由胰岛素介导的 FFAs 控制调节的。敲除小鼠模型结合复杂的分子技术证实了我们的生理发现和单一门户假说。